Target intelligence / Profile preview

Lipid radical (L•)

Target
L•
Molecular classification
Other, Free radicals, Reactive oxygen species derivatives, Lipid peroxidation intermediates
01

Overview

Lipid radicals are highly reactive chemical species generated during the process of lipid peroxidation within biological membranes. These radicals, which include carbon-centered (L•), peroxyl (LOO•), and alkoxyl (LO•) forms, typically arise when reactive oxygen species abstract hydrogen atoms from polyunsaturated fatty acids (PUFAs) (PMID: 24926803). Once formed, they initiate a self-propagating chain reaction that compromises membrane integrity, alters fluidity, and produces toxic secondary metabolites like 4-hydroxynonenal (PMID: 28853150). Lipid radicals are recognized as the primary drivers of ferroptosis, an iron-dependent form of regulated cell death implicated in various pathologies including neurodegeneration and ischemia (PMID: 22579052). Therapeutic intervention focuses on radical-trapping antioxidants (RTAs) and chain-breaking antioxidants, such as Vitamin E and Ferrostatin-1, which intercept these radicals to prevent cellular damage (PMID: 30115937). These agents work by donating a hydrogen atom to the radical, effectively terminating the oxidative cascade before it can cause irreversible membrane damage.

Other names
Lipid peroxyl radicalLipid alkoxyl radicalLipid carbon-centered radicalReactive lipid speciesLipid hydroperoxide radical
02

Mechanism of action

Radical-trapping antioxidants (RTAs) and chain-breaking antioxidants neutralize lipid radicals by donating a hydrogen atom, thereby terminating the self-propagating chain reaction of lipid peroxidation.

03

Biological functions

OtherLipid peroxidationCell deathMembrane degradationOxidative stress signaling
04

Disease associations

OtherNeurodegenerative diseaseCardiovascular diseaseCancerInflammationIschemia-reperfusion injury
05

Safety considerations

Interference with essential redox signalingPotential pro-oxidant effectsLow bioavailability in lipid bilayersOff-target metabolic effects
06

Interacting drugs

Alpha-tocopherol

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)F2-isoprostanes8-iso-PGF2alpha

Beyond the preview

Go deeper on Lipid radical (L•).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid radical (L•).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call